
Universe Pharmaceuticals Inc
Universe Pharmaceuticals Inc (UPC) is a very small-cap pharmaceutical company with a market capitalisation of about $2.96 million. For most investors this indicates high speculative risk: shares may be thinly traded, subject to large percentage moves, and sensitive to news flow about clinical data, regulatory milestones or financing. Small pharmas often rely on limited revenue, partnerships or milestone payments, and may need to raise capital, which can dilute shareholders. Key considerations include the company’s drug pipeline (if any), cash runway, management track record and intellectual property position. Because public information on microcaps can be sparse, investors should check official filings and be prepared for volatility and setbacks. This is educational information only and not personalised investment advice; microcap pharma stocks are generally suitable only for investors who understand high risk and potential loss of capital.
Stock Performance Snapshot
Financial Health
Universe Pharmaceuticals is generating good revenue and cash flow, showing a solid financial position.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring UPC
China's Biopharma Innovators: The Next Global Partnership Wave
Following GSK's major licensing deal with China's Jiangsu Hengrui, a new investment theme is emerging around Chinese pharmaceutical innovators. This theme focuses on other Chinese biopharma companies that are likely to attract similar global partnerships, driving value through their advanced drug development pipelines.
Published: July 28, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Tiny market cap
At roughly $3M market value, UPC is a microcap — movements can be large and trading thin, so price swings may be rapid and unpredictable.
Pipeline & regulation
Pharmaceutical value often hinges on clinical and regulatory milestones; positive data can lift sentiment, but failures can be costly.
Liquidity & news
With limited publicly available information, news and filings can drive big moves; perform careful due diligence and be aware of dilution risk.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.